right-img

Home | Robert W. Baird Reiterates Outperform Rating for Paratek Pharmaceuticals Inc. (PRTK)

Robert W. Baird Reiterates Outperform Rating for Paratek Pharmaceuticals Inc. (PRTK)

November 21, 2016
Paratek Pharmaceuticals Inc. (NASDAQ:PRTK)‘s stock had its “outperform” rating reaffirmed by equities researchers at Robert W. Baird in a research report issued to clients and investors on Sunday. They currently have a $40.00 price objective on the specialty pharmaceutical company’s stock. Robert W. Baird’s target price would suggest a potential upside of 210.08% from the […]
Read more at:https://www.americanbankingnews.com/2016/11/20/robert-w-baird-reiterates-outperform-rating-for-paratek-pharmaceuticals-inc-prtk.html

Site Created by finaceandbankingnewsnow.com